Effects of Single Oral Dose Dapagliflozin QT Study

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

The main purpose of this study is to examine the effect of dapagliflozin on electronic measures of heart beats in healthy males

Key facts

Study ID

NCT00688493

Run by

AstraZeneca

People needed

36

Starts

2007-07-01

Expected to finish

2008-04-01

Last updated by the study team

2012-03-21

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Healthy males age 18 to 45 years of age, who are not currently taking any medications
• Normal screening results including a physical examination, laboratory tests, heart rate, blood pressure, and ECG (electronic measure of the heart)

You may not qualify if…

• No personal or family history of significant heart problems
• No use of over the counter medications within 7 days of the study
• No use of prescription medicaiton within 1 month of the study

Where it is running

• Research Site — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.